The problem has never been the efficacy of Penthrox, its always been the uptake from hospitals, ambos etc. That's our real problem.
I haven't heard anything from MVP about how they plan to deal with that problem either, perhaps because they outsource distribution and think that is good enough.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
0.020(3.17%) |
Mkt cap ! $73.22M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 66.5¢ | 63.0¢ | $35.23K | 54.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| MVP (ASX) Chart |